Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome Cirrhosis happens when long term inflammation leads to permanent scarring in the liver, making it harder for this vital organ to perform its 500+ daily functions. There are two stages, compensated and decompensated A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non Alcoholic Fatty Liver Disease